Pembrolizumab and other immune checkpoint inhibitors in locally advanced or metastatic Merkel Cell Carcinoma: safety and efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab and other immune checkpoint inhibitors in locally advanced or metastatic Merkel Cell Carcinoma: safety and efficacy

Published:2020-11-04 Issue:12 Volume:20 Page:1093-1106
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Marchand Antoine¹,Kervarrec Thibault²³,Bhatia Shailender⁴⁵,Samimi Mahtab¹³

Affiliation:

1. Dermatology Department, University Hospital of Tours, Tours, France

2. Pathology Department, University Hospital of Tours, Tours, France

3. BIP (Biology of Polyomaviruses), ISP1282 INRA-University of Tours, Tours, France

4. Department of Medicine/Medical Oncology, University of Washington Medical Center, Seattle, Washington, USA

5. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2021.1835477

Reference69 articles.

1. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics

2. Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System

3. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline

4. Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Treatment Landscape of Merkel Cell Carcinoma;Current Treatment Options in Oncology;2023-07-05

2. Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response;Journal of Clinical Medicine;2022-06-11

3. Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors;Life;2021-12-15

4. Clinical impact of immunotherapy in Merkel cell carcinoma patients: A systematic review and meta-analysis;Journal of the American Academy of Dermatology;2021-04

5. The role of tissue fluorescence in in vivo optical bioimaging;Journal of Applied Physics;2020-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3